Cargando…

Doripenem Dosing Recommendations for Critically Ill Patients Receiving Continuous Renal Replacement Therapy

Doripenem dosing regimens for patients receiving continuous venovenous hemofiltration (CVVH) and continuous venovenous hemodiafiltration (CVVHDF) were devised based on an established efficacy criterion (free plasma doripenem concentrations above the minimum inhibitory concentration [fT > MIC] of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Samtani, Mahesh N., Vaccaro, Nicole, Cirillo, Iolanda, Matzke, Gary R., Redman, Rebecca, Nandy, Partha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scholarly Research Network 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3409546/ https://www.ncbi.nlm.nih.gov/pubmed/22888451 http://dx.doi.org/10.5402/2012/782656

Ejemplares similares

A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia
por: Kollef, Marin H, et al.
Publicado: (2012)

Flucytosine Pharmacokinetics in a Critically Ill Patient Receiving Continuous Renal Replacement Therapy
por: Kunka, Megan E., et al.
Publicado: (2015)

Drug Dosing Considerations in Critically Ill Patients Receiving Continuous Renal Replacement Therapy
por: Jang, Soo Min, et al.
Publicado: (2020)

Clinical Experience of Patients Receiving Doripenem-Containing Regimens for the Treatment of Healthcare-Associated Infections
por: Chao, Chien-Ming, et al.
Publicado: (2016)

1282. Ceftolozane/Tazobactam Use in Critically Ill Patients Receiving Intermittent or Continuous Renal Replacement Therapy
por: Henry, Molly, et al.
Publicado: (2021)

Relationship between serum phosphate and mortality in critically ill children receiving continuous renal replacement therapy
por: Zhou, Xiong, et al.
Publicado: (2023)

Associations of continuous anionic gap detection with the mortality in critically ill patients receiving renal replacement therapy
por: Zhai, Yiling, et al.
Publicado: (2023)

Disease progression model for Clinical Dementia Rating–Sum of Boxes in mild cognitive impairment and Alzheimer’s subjects from the Alzheimer’s Disease Neuroimaging Initiative
por: Samtani, Mahesh N, et al.
Publicado: (2014)

UHPLC–MS/MS method for simultaneous quantification of doripenem, meropenem, ciprofloxacin, levofloxacin, pazufloxacin, linezolid, and tedizolid in filtrate during continuous renal replacement therapy
por: Kai, Makoto, et al.
Publicado: (2022)

Continuous renal replacement therapy in critically ill neonates
por: Rödi, S, et al.
Publicado: (1998)

Continuous Renal Replacement Therapy in Critically Ill Children
por: Demirkol, Demet
Publicado: (2022)

Daily fluid balance predicts hospital mortality in critically ill patients receiving continuous renal replacement therapy
por: Kashiouris, M, et al.
Publicado: (2013)

Fluid overload and survival in critically ill patients with acute kidney injury receiving continuous renal replacement therapy
por: Kim, Il Young, et al.
Publicado: (2017)

Assessment of severity scoring systems for predicting mortality in critically ill patients receiving continuous renal replacement therapy
por: Park, Hyunmyung, et al.
Publicado: (2023)

Characteristics of doripenem: a new broad-spectrum antibiotic
por: Alvarez-Lerma, Francisco, et al.
Publicado: (2009)

Effectiveness of pharmacist dosing adjustment for critically ill patients receiving continuous renal replacement therapy: a comparative study
por: Jiang, Sai-Ping, et al.
Publicado: (2014)

Renal replacement therapy for critically ill patients: an intermittent continuity
por: Ricci, Zaccaria, et al.
Publicado: (2014)

Polymyxins and Doripenem Combination Against KPC-Producing Klebsiella pneumoniae
por: Lee, Grace C., et al.
Publicado: (2013)

Pleural fluid penetration of moxifloxacin and doripenem: An experimental model of empyema
por: Calik, Mustafa, et al.
Publicado: (2019)

Doripenem in the Treatment of Patients with Nosocomial Pneumonia: A Meta-Analysis
por: Huang, Chienhsiu, et al.
Publicado: (2022)

Isotherm data for adsorption of amoxicillin, ampicillin, and doripenem onto bentonite
por: Yeo, Jason Yi Juang, et al.
Publicado: (2023)

Cefepime dosing regimens in critically ill patients receiving continuous renal replacement therapy: a Monte Carlo simulation study
por: Chaijamorn, Weerachai, et al.
Publicado: (2018)

Fluid removal associates with better outcomes in critically ill patients receiving continuous renal replacement therapy: a cohort study
por: Hall, Anna, et al.
Publicado: (2020)

Modification of Nutrition Therapy During Continuous Renal Replacement Therapy in Critically Ill Pediatric Patients: A Narrative Review and Recommendations
por: Jonckheer, Joop, et al.
Publicado: (2018)

Association of doripenem resistance with OXA-type carbapenemases in Acinetobacter baumannii isolates
por: Terzi, Huseyin-Agah, et al.
Publicado: (2016)

Population pharmacokinetic analysis of doripenem for Japanese patients in intensive care unit
por: Nonoshita, Ko, et al.
Publicado: (2020)

A meta-analysis of efficacy and safety of doripenem for treating bacterial infections
por: Qu, Xiao-Yu, et al.
Publicado: (2015)

Long-term renal and overall survival of critically ill patients with acute renal injury who received continuous renal replacement therapy
por: Wu, Lingping, et al.
Publicado: (2017)

Continuous high-dose infusion of doripenem in a pneumonia patient infected by carbapenem-resistant Pseudomonas aeruginosa: a case report
por: Oda, Kazutaka, et al.
Publicado: (2019)

Pharmacokinetics and the optimal regimen for levofloxacin in critically ill patients receiving continuous hemodiafiltration
por: Wada, Takeshi, et al.
Publicado: (2015)

The effect of regional citrate anti-coagulation on the coagulation system in critically ill patients receiving continuous renal replacement therapy for acute kidney injury - an observational cohort study
por: Fisher, Richard, et al.
Publicado: (2017)

Clearance of meropenem during continuous renal replacement therapy in critically ill patients
por: Thalhammer, F, et al.
Publicado: (1999)

Pharmacokinetics of meropenem during continuous renal replacement therapy in critically ill patients
por: Solé Violan, J, et al.
Publicado: (2014)

Hemodynamic impact of the connection to continuous renal replacement therapy in critically ill children
por: Fernández, Sarah, et al.
Publicado: (2018)

Continuous renal replacement therapy in critically ill children: single-center experience
por: ERKOL TUNCER, Hatice, et al.
Publicado: (2021)

Body temperature and infection in critically ill patients on continuous kidney replacement therapy
por: Challener, Douglas W., et al.
Publicado: (2023)

Fingolimod Promotes Antibacterial Effect of Doripenem against Carbapenem-Resistant Escherichia coli
por: Jin, Hye-Won, et al.
Publicado: (2022)

Pharmacokinetics and Safety of Doripenem in Healthy Chinese Subjects and Monte Carlo Dosing Simulations
por: Wang, Yu, et al.
Publicado: (2022)

The doripenem serum concentrations in intensive care patients suffering from acute kidney injury, sepsis, and multi organ dysfunction syndrome undergoing continuous renal replacement therapy slow low-efficiency dialysis
por: Wieczorek, Andrzej, et al.
Publicado: (2014)

Continuous infusion of ceftazidime in critically ill patients undergoing continuous venovenous haemodiafiltration: pharmacokinetic evaluation and dose recommendation
por: Mariat, Christophe, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_d26ck767t0t39j712s944nrlol